Skip to main content

Table 7 Baseline Clinical Characteristics

From: Clinical results of bioresorbable drug-eluting scaffolds in short and long coronary artery lesions using the PSP technique

 

Patients without Event

Patients with Event

P-values

Number of patients

298

28

 

Age, years

61.7 ± 10.6

64.1 ± 9.5

0.24

Male sex, N (%)

231 (77.5)

21 (75.0)

0.76

Hypertension, N (%)

226 (75.8)

24 (85.7)

0.21

Diabetes mellitus, N (%)

59 (19.8)

8 (28.6)

0.29

Hyperlipidemia, N (%)

234 (78.5)

20 (71.4)

0.40

History of smoking, N (%)

154 (51.7)

20 (71.4)

0.22

Renal insufficiency, N (%)

24 (8.1)

8 (28.6)

0.009

Body mass index, kg/m2

27.7 ± 4.7

27.4 ± 5.0

0.74

Family history, N (%)

116 (38.9)

10 (35.7)

0.02

Number of diseased vessels

2.3 ± 0.8

2.4 ± 0.7

0.38

Stable angina, N (%)

167 (56.0)

16 (57.1)

0.91

ACS, N (%)

131 (44.0)

12 (42.9)

0.91

  1. Data are presented as mean value±SD or percentage of patients. ACS: acute coronary syndrome